Abstract. The effects of Phx-3 on changes in intracellular pH (pH i ) in the MKN45 and MKN74 human gastric cancer cell lines were evaluated in order to determine the mechanism for the proapoptotic effects of 2-aminophenoxazine-3-one (Phx-3) on these cells. Phx-3 (100 μM) reduced pH i in MKN45 from 7.45 to 5.8, and in MKN74 from 7.5 to 6.2 within 1 min of engagement with these cells. Such a decrease of pH i was closely correlated with the dose of this phenoxazine and continued for 4 h. The activity of Na + /H + exchanger isoform l (NHE1), which is involved in H + extrusion from the cells, was dose-dependently suppressed by Phx-3 in these cells, and was greatly suppressed in the presence of 100 μM Phx-3. This result indicates that the decrease of pH i in MKN45 and MKN74 cells is closely associated with the inhibition of NHE1 in these cells. The morphology of these cells at 24 h after treatment with Phx-3 indicated shrinkage of the cells and condensation of the nuclear chromatin structure, which are characteristic of the apoptotic events in these gastric cancer cells. Cytotoxicity of Phx-3 against MKN45 and MKN74 cells was extensive because almost all MKN45 cells lost viability at 24 h in the presence of 20 μM Phx-3, and nearly 50% of the MKN74 cells lost viability in the presence of 50 μM Phx-3. These results suggest that rapid and extensive decrease of pH i in human gastric cancer MKN45 and MKN74 cells caused by Phx-3 might disturb intracellular homeostasis, leading to apoptotic and cytotoxic events in these cells. Phx-3 is a good candidate for therapeutics of gastric cancer that is intractable to conventional chemopreventive therapies.
IntroductionIt has been suggested that a decrease of intracellular pH (pH i ) precedes apoptotic events in cancer cells (1,2). Therefore, drugs to induce pH i reduction have been considered good candidates for treating cancer and causing programmed cell death (3). For example, cyclohexamide, etoposide, and camptothesin decrease pH i in cancer cells, leading to apoptosis of the cells (3-5); however, these drugs often exert significant adverse effects on the body (6,7).The oxidative phenoxazines [e.g., 2-amino-4,4·-dihydro-4·,7-dimethyl-3H-phenoxazine-3-one (Phx-1) and 2-aminophenoxazine-3-one (Phx-3)] exert anticancer effects on various species of cancer cells in vitro (8-10) and in vivo, without marked adverse effects (11-13). Recently, Che et al (14) reported that apoptotic events in KB-3-1 cells (human epidermoid carcinoma cell line) and K562 cells (human chronic myeloid leukemia cell line) are preceded by a decrease in pH i in cells treated with Phx-3, a phenoxazine produced by the reaction of o-aminophenol with bovine hemoglobin. However, the detailed mechanism for pH i decrease in these cancer cells with Phx-3 remains unclear.Regarding the regulation of pH i , it has been suggested that among Na + /H + exchangers, Na + /H + exchanger isoform 1 (NHE1) is ubiquitously present in the plasma membrane in the cells and plays a pivotal role in regulating pH i (15)(16)(17). Therefore...